StathmonCustom AI systems, built around the way your company works.

Selected work in pharmaceuticals, energy and financeGeorgios Vamvouras · 20+ peer-reviewed publications · 5+ clients

AthensContents

Work

Chapter 1. Regulatory document comparison

WinMedica
Pharmaceutical

Every word on the pack checked against the approved text.

Approved text Printed artwork 1 difference found
Fig. 1 Approved text, left; printed artwork, right. The line that differs is marked in red.

Leaflets, cartons and blisters, aligned word by word, every difference marked where it is. In daily use by three departments.

More

Chapter 2. Pharmaceutical market forecasting

WinMedica
Pharmaceutical

Every pack in 77 countries, three years ahead: how it will move, and why.

Forecast file, 2026–20283 of 1.26 million rows
Molecule A 5 mg, 60 tabletsSpain Patent expires Jun 2026.Mar 2027. Generics enter and the originator’s price falls. Updated
Molecule B 1 mg penGermany Launched mid-2025, so the data holds only part of a year.
Molecule C 100 mg vialItaly Withdrawn by the company in March 2026, with the source recorded.
Fig. 2 77 countries, some 300,000 brands, 1.26 million rows. The rows shown are illustrative. history forecast

Built on a licensed global sales panel: sales and volume for every product in every country, history and forecast on the same row. Patent expiries, generic entries, launches, withdrawals and national price rules move the rows they touch. Unlike most market forecasts, every row names the reason behind its number.

More

Chapter 3. Personalised intelligence gathering

VP&C
Pharmaceutical policy

A digest built around the reader’s interests, every item checked against its source.

Intelligence digestThursday 16 October
3 items, all verified
Pharma regulatoryPricing & reimbursementTendersClinical
Variation guideline updated for labelling changes
Agency guideline, 15 Octverified against source
October price list published, two products in the lower band
Committee bulletin, 16 Octverified against source
Hospital tender for oncology supplies closes 30 October
Tender notice, 14 Octverified against source
Fig. 3 One morning’s digest, set to pharma regulatory, pricing and tenders.

In use by large pharmaceutical companies and national policy-makers.

Chapter 4. Solar and battery sizing for a factory

WinMedica
Energy

Sized and costed end to end, using methods from our published work.

48-hour site weather forecast Solar array1,500+ kWh per kWp a year Batterycharged cheap Pharmaceutical plantPlantits own load, forecast Gridbuy and sell
Fig. 4 Site, plant and grid. Solar array: 1,500+ kWh per kWp a year. Battery: charged cheap. Plant: its own load, forecast. Grid: buy and sell.

Weather, price and load forecasting, energy yield, battery dispatch, feasibility and lifecycle analysis. Efficiency, reliability and revenue, each quantified.

Chapter 5. Battery trading controller

Lab.RACSE, NTUA
Energy

82% of the theoretical maximum.

Fig. 5 Revenue over a year, against the theoretical maximum. theoretical maximum our controller fixed rule

The maximum is what a battery would earn if it knew tomorrow’s prices and had the perfect plan. Our learned controller comes that close with real forecasts, and outperforms all the popular industry methodologies.

Chapter 6. Electricity price and weather forecasting

Lab.RACSE, NTUA
Energy

Scored on a full year the models never saw.

Fig. 6 Greek day-ahead market, one day. forecast, made the day before cleared price

Deep-learning forecasters for hourly prices and 48-hour temperature, irradiance and humidity, published. The same forecasts powered the analysis of WinMedica’s Tripoli plant (chapter 4).

Chapter 7. Automated portfolio management

Unnamed private investor
Finance

Most of the stock market’s growth, with about half the fall in a crash.

Fig. 7 An illustration: the portfolio against a single market index, through three crises. the portfolio a single market index crisis periods

A portfolio that runs itself, while the investor stays in control. In historical tests it has earned about 9.6% a year since 2012, similar to a well-engineered stock-heavy portfolio, and in the 2008 crisis it lost only about half as much.

More

Chapter 8. Right Hand, a personal assistant

Stathmon
In-house product

An assistant that gets to know you.

Right Hand
07:40Brief sent. One push held overnight, delivered.
Morning. Three things fit today: the Petrou quote (2h), the server deploy (half a day), the Andreou follow-up (20m). Maria at Petrou expects the quote by Friday.
Move the Petrou quote to Friday and remind me Thursday morning.
Done. Quote due Friday, reminder Thursday 08:00. Nothing else changed.
Send revised quotemoved2hFri
ChatTasksMore
Fig. 8 The app, on your own server.

Tell it what you need, by voice or in writing. It keeps your tasks and reminders, reads what you share with it, learns how you work and answers from what it knows about you. Access it from your phone or the web.

More

Also built

  1. 9

    Custom word segmentation pipelines

    Local detectors trained on the client’s own documents find every word on pharmaceutical artwork, more precisely than the strongest commercial alternative.

    WinMedica
  2. 10

    Pharmaceutical OCR, Greek and English

    Reads Greek and English pack text more accurately than the commercial cloud OCR services. Built for regulatory documents.

    WinMedica
  3. 11

    Greek invoice reader

    Structured fields from scanned invoices of varied layouts. Validated and commercialised.

    VisionIT
  4. 12

    Private language models

    Open-weight models deployed and benchmarked on your own GPUs or HPC allocation, so data stays on-premise. Depending on the task, they reach 80–100% of the capability of the best closed frontier models.

  5. 13

    Heat-pump performance across refrigerants

    Regression models that predict cycle performance, including fluids not seen in training.

    Lab.RACSE, NTUA
  6. 14

    Plugins for energy design software

    Plugins for building energy software such as IDA ICE that run automated design optimisation on the model.

    Lab.RACSE, NTUA

How we work

  1. 1

    Scope

    We start from the workflow, the data and the decision, with the people who will use the system, and agree what will be measured.

  2. 2

    Build

    We build on your own data, with published methods or our own research, and test against the cases that matter to you before anything is used.

  3. 3

    Hand-over

    The system runs on your infrastructure or ours, with documentation, training and continuing support.

The founder

Georgios Vamvouras

Georgios Vamvouras

Founder and principal engineer. PhD candidate in Energy and AI; MSc Data Science and Machine Learning (2027); Dipl.-Ing. Mechanical Engineering. National Technical University of Athens.

More

Contact

[email protected]

Tell us the workflow, data or decision you want to create or improve.